Rigel Pharmaceuticals, Inc. (RIGL)
29.01
-2.91
(-9.12%)
USD |
NASDAQ |
May 15, 16:00
29.15
+0.14
(+0.48%)
Pre-Market: 08:27
Rigel Pharmaceuticals Research and Development Expense (Quarterly) : 11.68M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Arvinas, Inc. | 60.00M |
| Pfizer Inc. | 2.452B |
| Amgen, Inc. | 1.719B |
| Madrigal Pharmaceuticals, Inc. | 108.31M |
| Xencor, Inc. | 64.67M |